Plastiape

Exited PM&Partners II

Development and production of respiratory medical devices and other plastic pharmaceutical and personal care packaging solutions

INVESTMENT RATIONALE
  • Positive market growth prospects linked to population demographics and increasing respiratory diseases
  • Healthy customer base including large multinational clients holding long-term exclusive production contracts
  • High entry barriers both in terms of capital and know how
  • Highly experienced and motivated management
Shareholding
PM&P: 77.7 %
Founders & Management Stake: 22.3 %
Industry
Medical devices
SALES
51.6 €M
EBITDA
10.0 €M
EBITDA Margin
19.4 %
Website

Our investments